| Literature DB >> 7037294 |
Abstract
When measurements developed for the diagnosis of patients are used to detect treatment effects in clinical trials with chronic disease, problems in definition of response and in the statistical distributions of those measurements within patients have to be resolved before the results of clinical studies can be analyzed. An example of this process is shown in the development of the analysis of single-dose bronchodilator trials.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7037294 DOI: 10.1016/0197-2456(81)90020-9
Source DB: PubMed Journal: Control Clin Trials ISSN: 0197-2456